ehealth digital library

Digital library of
the Tanzania
health
community

Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-child-transmission of HIV in Tanzania.

Ziske, J., Kunz, A., Sewangi, J., Lau, I., Dugange, F., Hauser, A., Kirschner, W., Harms, G. and Theuring, S. (2013) Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-child-transmission of HIV in Tanzania. PloS one, 8 (2). e55633. ISSN 1932-6203

[img]
Preview
PDF
Judith_Ziske.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (363kB)

Abstract

Tanzanian guidelines for prevention of mother-to-child-transmission of HIV (PMTCT) recommend an antiretroviral combination regimen involving zidovudine (AZT) during pregnancy, single-dosed nevirapine at labor onset, AZT plus Lamivudine (3TC) during delivery, and AZT/3TC for 1-4 weeks postpartum. As drug toxicities are a relevant concern, we assessed hematological alterations in AZT-exposed women and their infants. A cohort of HIV-positive women, either with AZT intake (n = 82, group 1) or without AZT intake (n = 62, group 2) for PMTCT during pregnancy, was established at Kyela District Hospital, Tanzania. The cohort also included the infants of group 1 with an in-utero AZT exposure ≥4 weeks, receiving AZT for 1 week postpartum (n = 41), and infants of group 2 without in-utero AZT exposure, receiving a prolonged 4-week AZT tail (n = 58). Complete blood counts were evaluated during pregnancy, birth, weeks 4-6 and 12. For women of group 1 with antenatal AZT intake, we found a statistically significant decrease in hemoglobin level, red blood cells, white blood cells, granulocytes, as well as an increase in red cell distribution width and platelet count. At delivery, the median red blood cell count was significantly lower and the median platelet count was significantly higher in women of group 1 compared to group 2. At birth, infants from group 1 showed a lower median hemoglobin level and granulocyte count and a higher frequency of anemia and granulocytopenia. At 4-6 weeks postpartum, the mean neutrophil granulocyte count was significantly lower and neutropenia was significantly more frequent in infants of group 2. AZT exposure during pregnancy as well as after birth resulted in significant hematological alterations for women and their newborns, although these changes were mostly mild and transient in nature. Research involving larger cohorts is needed to further analyze the impact of AZT-containing regimens on maternal and infant health.

Item Type: Article
Keywords: Hematological,PMCT, HIV, Antiretroviral combination, labor, kyela, Tanzania
Subjects: HIV > PMTCT (prevention of mother-to-child transmission)
Divisions: Other
Depositing User: Mr Joseph Madata
Date Deposited: 24 Oct 2013 08:07
Last Modified: 24 Oct 2013 08:07
URI: http://ihi.eprints.org/id/eprint/2217

Actions (login required)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics